Proteome Analysis of Gelatin-Bound Urinary Proteins from Patients with Bladder Cancers

Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide Gels

1996 • 8,994 citations

Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates

1980 • 1,991 citations

TNM classification of malignant tumors, fifth edition (1997)

1997 • 982 citations

Tumor invasion and the extracellular matrix.

1983 • 960 citations

Biochemistry and Molecular Biology of Gelatinase B or Matrix Metalloproteinase-9 (MMP-9)

2002 • 901 citations

Mass spectrometric identification of proteins from silver-stained polyacrylamide gel: A method for the removal of silver ions to enhance sensitivity

1999 • 896 citations

Matrix metalloproteinases in tumour invasion and metastasis

1999 • 670 citations

Sample application by in‐gel rehydration improves the resolution of two‐dimensional electrophoresis with immobilized pH gradients in the first dimension

1994 • 367 citations

Use of a New Tumor Marker, Urinary NMP22, in the Detection of Occult or Rapidly Recurring Transitional Cell Carcinoma of the Urinary Tract Following Surgical Treatment

1996 • 330 citations

Results of a Multicenter Trial using the BTA Test to Monitor for and Diagnose Recurrent Bladder Cancer

1995 • 231 citations

A Multicenter Trial Evaluation of the Fibrin/Fibrinogen Degradation Products Test for Detection and Monitoring of Bladder Cancer

1997 • 122 citations

Enhanced urinary gelatinase activities (matrix metalloproteinases 2 and 9) are associated with early-stage bladder carcinoma: a comparison with clinically used tumor markers.

2000 • 79 citations

Mass spectrometric approaches for the characterization of proteins on a hybrid quadrupole time-of-flight (Q-TOF) mass spectrometer

2000 • 70 citations

Urinary type IV collagenase: elevated levels are associated with bladder transitional cell carcinoma.

1992 • 65 citations

Evaluation of two new urinary tumor markers: bladder tumor fibronectin and cytokeratin 18 for the diagnosis of bladder cancer.

2000 • 41 citations

N-Glycosylation pattern of the zymogenic form of human matrix metalloproteinase-9

2002 • 37 citations

The role of the activated form of matrix metalloproteinase‐2 in urothelial cancer

2000 • 27 citations

Urinary fibronectin fragments (a potential tumor marker) measured by immunoenzymometric assay with domain-specific monoclonal antibodies.

1991 • 27 citations

Use of a New Tumor Marker, Urinary NMP22, in the Detection of Occult or Rapidly Recurring Transitional Cell Carcinoma of the Urinary Tract Following Surgical Treatment

1996 • 26 citations

A Multicenter Trial Evaluation of the Fibrin/Fibrinogen Degradation Products Test for Detection and Monitoring of Bladder Cancer

1997 • 13 citations

Results of a Multicenter Trial using the BTA Test to Monitor for and Diagnose Recurrent Bladder Cancer

1995 • 10 citations